Monica Bertagnolli - 08 Sep 2021 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
Director
Signature
/s/ Douglas E. Onsi, as Attorney-in-Fact for Monica Bertagnolli
Issuer symbol
LPTX
Transactions as of
08 Sep 2021
Net transactions value
$0
Form type
4
Filing time
10 Sep 2021, 21:01:00 UTC
Previous filing
02 Jun 2021
Next filing
19 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Stock Option (Right to Buy) Award $0 +65,000 $0.000000 65,000 08 Sep 2021 Common Stock 65,000 $1.58 Direct F1
transaction LPTX Stock Option (Right to Buy) Award $0 +16,150 $0.000000 16,150 08 Sep 2021 Common Stock 16,150 $1.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 12 equal quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of September 8, 2021, the Vesting Start Date.
F2 The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable with respect to 50% of the Option on September 30, 2021, and with respect to the remaining 50% of the Option on December 31, 2021.